Tectonic Therapeutic
Price & Volume
Stats
See moreOpen | $20.81 |
Previous Close | $20.56 |
Day Range | $20.35-$21.35 |
52W Range | $15.52-$39.53 |
Market Cap | $401.9M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.62 |
News
See moreYahoo Finance • 5 months ago
Tectonic Completes Enrollment In Phase 2 APEX Trial For TX-45 In Pulmonary Hypertension Subtype
Yahoo Finance • 8 months ago
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Yahoo Finance • 9 months ago
Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026
Yahoo Finance • 12 months ago
Tectonic Therapeutic Surges 12% On Positive Phase 1b Topline Data For TX45
About
CEO | Dr. Alise S. Reicin M.D., Ph.D. |
Address | 490 Arsenal Way, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 60 |